' Cancer Bio-Immunotherapy in Siena': Eleventh Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 17-19, 2013.
- Published in:
- 2015
- By:
- Publication type:
- Report
Works matching IS 03407004 AND DT 2015 AND VI 64 AND IP 1
Results: 14
1
2
Cancer stem cells: perspectives for therapeutic targeting.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 1, p. 91, doi. 10.1007/s00262-014-1592-1
- By:
- Publication type:
- Article
3
Somatically mutated tumor antigens in the quest for a more efficacious patient-oriented immunotherapy of cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 1, p. 99, doi. 10.1007/s00262-014-1599-7
- By:
- Publication type:
- Article
4
Evaluation of complement proteins as screening markers for colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 1, p. 41, doi. 10.1007/s00262-014-1615-y
- By:
- Publication type:
- Article
5
CTLA4 blockade in mesothelioma: finally a competing strategy over cytotoxic/target therapy?
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 1, p. 105, doi. 10.1007/s00262-014-1609-9
- By:
- Publication type:
- Article
6
Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 1, p. 61, doi. 10.1007/s00262-014-1610-3
- By:
- Publication type:
- Article
7
Identification of tumor-binding scFv derived from clonally related B cells in tumor and lymph node of a patient with breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 1, p. 29, doi. 10.1007/s00262-014-1612-1
- By:
- Publication type:
- Article
8
Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 1, p. 51, doi. 10.1007/s00262-014-1613-0
- By:
- Publication type:
- Article
9
Novel N-amidinopiperidine-based proteasome inhibitor preserves dendritic cell functionality and rescues their Th1-polarizing capacity in Ramos-conditioned tumor environment.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 1, p. 15, doi. 10.1007/s00262-014-1608-x
- By:
- Publication type:
- Article
10
Cytokine production in peripheral blood cells of patients with differentiated thyroid cancer: elevated Th2/Th9 cytokine production before and reduced Th2 cytokine production after radioactive iodine therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 1, p. 75, doi. 10.1007/s00262-014-1619-7
- By:
- Publication type:
- Article
11
Armed antibodies for cancer treatment: a promising tool in a changing era.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 1, p. 113, doi. 10.1007/s00262-014-1621-0
- By:
- Publication type:
- Article
12
Tumor-induced myeloid dysfunction and its implications for cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 1, p. 1, doi. 10.1007/s00262-014-1639-3
- By:
- Publication type:
- Article
13
Overcoming the toxicity hurdles of genetically targeted T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 1, p. 123, doi. 10.1007/s00262-014-1641-9
- By:
- Publication type:
- Article
14
Modulation of the myeloid compartment of the immune system by angiogenic- and kinase inhibitor-targeted anti-cancer therapies.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 1, p. 83, doi. 10.1007/s00262-014-1576-1
- By:
- Publication type:
- Article